Developer docs
API playgroundTry for free, no card

Search company profiles

RedLeaf Biologics

Full company profile

uuid0002lnj

Namestring
RedLeaf Biologics
Legal namestring
RedLeaf Biologics
Company typeenum
Private
Founded yearint
2009
Descriptiontext

RedLeaf Biologics is a private Kentucky-based ingredient company that produces and sells ReDaxin™, a patented red sorghum leaf extract marketed as a bioactive ingredient for dietary supplement, functional food and beverage, and cosmetic manufacturers. Founded in 2015 and tracing its core genetic asset to a one-in-two-million red sorghum plant discovered in a Kentucky sorghum field in 2009, the company operates a fully U.S.-based, SQF-certified seed-to-extract value chain in which it partners with domestic farmers to grow its patented non-GMO red sorghum varietal and processes the leaves in-house.

ReDaxin is the company's sole commercial product and is positioned as the first and only patented red sorghum leaf extract, a phenolic-rich botanical containing greater than 20% polyphenols, including luteolin, quercetin, hydroxycinnamic acids, and rare 3-deoxyanthocyanidins. The extract is produced via a proprietary aqueous (water-based) extraction process that yields a water-soluble, clean-label ingredient stable across a broad pH range, temperature, and light conditions, and is supplied in formats spanning capsules, tablets, ready-to-drink beverages, powders, stick packs, gummies, gels, functional foods, and cosmetic applications. Recent validation includes a 2025 University of Kentucky clinical study showing enhanced muscle strength recovery after eccentric exercise.

RedLeaf generates revenue through quote-based B2B ingredient supply agreements with formulators, with pricing not publicly disclosed. Commercial engagement is consultative, with prospects requesting samples, clinical study data, and quotes via the company website. ReDaxin is supported by a broad certification stack — self-affirmed GRAS, Non-GMO Project Verified, Kosher, Halal, Vegan, Gluten-Free, Made in America, and TruShield (received November 2025) — and is positioned for high-purity, clean-label formulation across regulated end-markets. The company has been grant-funded, including two NSF SBIR awards totaling approximately $1.53M and a 2024 Bluegrass AgTech Development Corp grant, and is led by co-founder and CEO Seth DeBolt, co-founder Heather Youngs, and co-founder Chris Somerville.

Short descriptiontext

RedLeaf Biologics produces ReDaxin, a patented red sorghum leaf extract used as a bioactive ingredient by formulators in dietary supplements, functional food and beverage, and cosmetics, via a U.S.-based, SQF-certified seed-to-extract value chain using proprietary aqueous extraction.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLexington, United States
HQ citystring
Lexington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
botanical extract ingredients, natural bioactive ingredients, polyphenol antioxidants, dietary supplement ingredients, functional food colorants
Industry3 codes
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAKAI
Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAGAD
Herbal & Botanical Supplements
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Botanical Extract Ingredients
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales to Formulators
TypeHardware Sales
Description

RedLeaf Biologics sells its patented ReDaxin™ red sorghum leaf extract as a raw bioactive ingredient to formulators and brand manufacturers in the dietary supplement, functional food & beverage, and cosmetics industries via inquiry-based B2B engagement. Revenue is generated through ingredient supply agreements (B2B sales of physical ingredient SKUs).

redleafbiologics.com
Cost components5 values
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales
Pricing details1 tier
1Quote-based B2B ingredient pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed; available on request via the contact form. Available pack formats mentioned in applications include powders, stick packs, ready-to-drink, gummies/gels, capsules/tablets.

redleafbiologics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ReDaxin
Description

Patented red sorghum leaf extract; the first and only patented red sorghum leaf extract, a phenolic-rich botanical extract marketed for dietary supplement, functional food and beverage, and cosmetic applications.

redleafbiologics.com
Core offering1 text field

RedLeaf Biologics produces and sells ReDaxin™, a patented red sorghum leaf extract — a phenolic-rich (>20% polyphenols, including rare 3-deoxyanthocyanidins) botanical extract manufactured through a proprietary aqueous extraction process. The extract is sold as a formulation-ready bioactive raw ingredient to product manufacturers in the dietary supplement, functional food and beverage, and cosmetics industries, in multiple delivery formats including capsules/tablets, ready-to-drink beverages, powders and stick packs, gummies and gels, and cosmetic applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

RedLeaf Biologics offers a single flagship branded product — ReDaxin™ — rather than a multi-module platform. ReDaxin is the company's patented red sorghum leaf extract and is the central commercial offering around which all company messaging, R&D, clinical work, and certifications are organized. The extract is supplied as one core ingredient delivered across multiple application formats (capsules and tablets, ready-to-drink beverages, powders and stick packs, gummies and gels, functional foods, and cosmetic applications), rather than as a suite of distinct sub-products or modules. Supporting capabilities — including the proprietary non-GMO seed-to-extract U.S. value chain, plant-genetics and phytochemistry R&D, and clinical research in sports nutrition, cognition, and immune health — are positioned as enablers of the ReDaxin offering rather than as separately sold products.

Product and service1 record
1ReDaxin™
CategoryBotanical Extract Ingredient (Bioactive Raw Material)
Description

ReDaxin™ is the first and only patented red sorghum leaf extract — a phenolic-rich botanical extract (>20% polyphenols, including luteolin, quercetin, hydroxycinnamic acids, and rare 3-deoxyanthocyanidins) produced via a proprietary aqueous extraction process. It is supplied as a formulation-ready bioactive raw ingredient for dietary supplement, functional food and beverage, and cosmetic applications, available in formats including capsules/tablets, ready-to-drink beverages, powders/stick packs, gummies/gels, functional foods, and cosmetic applications. Demonstrated functionality includes muscle strength recovery support, reduced muscle soreness, antioxidant activity, anti-inflammatory action, and immune modulation, with a University of Kentucky clinical study supporting the muscle strength recovery claim.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global ingredient manufacturer supplying natural antioxidants, colorants, and antimicrobials to F&B, supplement, and pet/animal nutrition formulators. Comparable to RedLeaf as a botanical/bioactive ingredient supplier targeting the same B2B customer base, though Kemin operates a vastly larger, multi-ingredient portfolio.

TypeBroad incumbent
Description

Major agribusiness with a large Nutrition and Health Solutions segment supplying plant-based extracts, natural colors, and functional ingredients to F&B and supplement manufacturers. Directly comparable to RedLeaf on supply-side agronomy and ingredient-channel economics, with much greater scale.

TypeBroad incumbent
Description

Through its Naturex acquisition, Givaudan is one of the largest suppliers of botanical extracts, natural colors, and fruit/vegetable-derived ingredients to F&B and nutraceutical formulators globally. Closest direct peer in the natural polyphenol/botanical extract category, but at incumbent scale.

TypeDirect peer
Description

Italian botanical extract specialist supplying high-purity, clinically supported plant-derived active ingredients to dietary supplement, functional food, and cosmetic formulators. Directly comparable to RedLeaf on the botanical-ingredient-for-formulators model and clinical-evidence-led selling motion.

TypeDirect peer
Description

Supplier of patented, clinically-studied branded botanical extracts (e.g., Curcumin C3 Complex, BioPerine) to dietary supplement and functional food manufacturers. Highly comparable go-to-market: patented ingredient + clinical substantiation + B2B sales to formulators.

TypeDirect peer
Description

Supplier of proprietary, science-backed botanical extracts (e.g., Lutemax, CurcuWin) to dietary supplement and functional food brands. Comparable branded-ingredient business model with clinical study support and a focus on differentiated polyphenol/carotenoid actives.

TypeDirect peer
Description

U.S.-based distributor and developer of branded nutraceutical ingredients, including plant extracts, polyphenols, and functional food/beverage actives. Closely comparable in customer base (U.S. supplement and F&B formulators) and ingredient-platform approach.

TypeDirect peer
Description

Developer of clean-label, plant-based ingredients (e.g., Sondr Sleep, Relissa) sold to CPG and supplement brands. Comparable in positioning around proprietary, branded, natural actives marketed on clinical or mechanistic evidence.

TypeDirect peer
Description

Supplier of proprietary fruit-, vegetable-, and plant-derived ingredient powders and extracts to supplement, beverage, and functional food formulators, with clinical research support. Comparable in the proprietary-ingredient-for-formulators niche.

TypeBroad incumbent
Description

Global bioscience company supplying natural colors, antioxidants, and antimicrobial cultures to food and beverage manufacturers. Directly comparable on the natural colorant + antioxidant + antimicrobial function that RedLeaf is targeting, though at incumbent scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RedLeaf Biologics

Botanical Extract Ingredientsredleafbiologics.com

RedLeaf Biologics produces ReDaxin, a patented red sorghum leaf extract used as a bioactive ingredient by formulators in dietary supplements, functional food and beverage, and cosmetics, via a U.S.-based, SQF-certified seed-to-extract value chain using proprietary aqueous extraction.

What RedLeaf Biologics does

RedLeaf Biologics is a private Kentucky-based ingredient company that produces and sells ReDaxin™, a patented red sorghum leaf extract marketed as a bioactive ingredient for dietary supplement, functional food and beverage, and cosmetic manufacturers. Founded in 2015 and tracing its core genetic asset to a one-in-two-million red sorghum plant discovered in a Kentucky sorghum field in 2009, the company operates a fully U.S.-based, SQF-certified seed-to-extract value chain in which it partners with domestic farmers to grow its patented non-GMO red sorghum varietal and processes the leaves in-house.

ReDaxin is the company's sole commercial product and is positioned as the first and only patented red sorghum leaf extract, a phenolic-rich botanical containing greater than 20% polyphenols, including luteolin, quercetin, hydroxycinnamic acids, and rare 3-deoxyanthocyanidins. The extract is produced via a proprietary aqueous (water-based) extraction process that yields a water-soluble, clean-label ingredient stable across a broad pH range, temperature, and light conditions, and is supplied in formats spanning capsules, tablets, ready-to-drink beverages, powders, stick packs, gummies, gels, functional foods, and cosmetic applications. Recent validation includes a 2025 University of Kentucky clinical study showing enhanced muscle strength recovery after eccentric exercise.

RedLeaf generates revenue through quote-based B2B ingredient supply agreements with formulators, with pricing not publicly disclosed. Commercial engagement is consultative, with prospects requesting samples, clinical study data, and quotes via the company website. ReDaxin is supported by a broad certification stack — self-affirmed GRAS, Non-GMO Project Verified, Kosher, Halal, Vegan, Gluten-Free, Made in America, and TruShield (received November 2025) — and is positioned for high-purity, clean-label formulation across regulated end-markets. The company has been grant-funded, including two NSF SBIR awards totaling approximately $1.53M and a 2024 Bluegrass AgTech Development Corp grant, and is led by co-founder and CEO Seth DeBolt, co-founder Heather Youngs, and co-founder Chris Somerville.

RedLeaf Biologics firmographics

Firmographics
Name
RedLeaf Biologics
Legal name
RedLeaf Biologics
Website
https://redleafbiologics.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
RedLeaf Biologics produces ReDaxin, a patented red sorghum leaf extract used as a bioactive ingredient by formulators in dietary supplements, functional food and beverage, and cosmetics, via a U.S.-based, SQF-certified seed-to-extract value chain using proprietary aqueous extraction.
Ownership category
akta.pro rank

RedLeaf Biologics industry classification

Industry
Product category
Botanical Extract Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAKAI
Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAGAD
Herbal & Botanical Supplements

Keywords

  • Botanical extract ingredients
  • Natural bioactive ingredients
  • Polyphenol antioxidants
  • Dietary supplement ingredients
  • Functional food colorants

Where RedLeaf Biologics is headquartered

Location

Headquarters

HQ city
Lexington
HQ country
United States
HQ region
North America

Markets served

RedLeaf Biologics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales to Formulators: RedLeaf Biologics sells its patented ReDaxin™ red sorghum leaf extract as a raw bioactive ingredient to formulators and brand manufacturers in the dietary supplement, functional food & beverage, and cosmetics industries via inquiry-based B2B engagement. Revenue is generated through ingredient supply agreements (B2B sales of physical ingredient SKUs).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based B2B ingredient pricing

Go-to-market motion2 records

RedLeaf Biologics product offering

Product offering

Core offering

RedLeaf Biologics produces and sells ReDaxin™, a patented red sorghum leaf extract — a phenolic-rich (>20% polyphenols, including rare 3-deoxyanthocyanidins) botanical extract manufactured through a proprietary aqueous extraction process. The extract is sold as a formulation-ready bioactive raw ingredient to product manufacturers in the dietary supplement, functional food and beverage, and cosmetics industries, in multiple delivery formats including capsules/tablets, ready-to-drink beverages, powders and stick packs, gummies and gels, and cosmetic applications.

Product overview

RedLeaf Biologics offers a single flagship branded product — ReDaxin™ — rather than a multi-module platform. ReDaxin is the company's patented red sorghum leaf extract and is the central commercial offering around which all company messaging, R&D, clinical work, and certifications are organized. The extract is supplied as one core ingredient delivered across multiple application formats (capsules and tablets, ready-to-drink beverages, powders and stick packs, gummies and gels, functional foods, and cosmetic applications), rather than as a suite of distinct sub-products or modules. Supporting capabilities — including the proprietary non-GMO seed-to-extract U.S. value chain, plant-genetics and phytochemistry R&D, and clinical research in sports nutrition, cognition, and immune health — are positioned as enablers of the ReDaxin offering rather than as separately sold products.

Differentiator

Problem solved

Functional benefit

Brands

  • ReDaxin: Patented red sorghum leaf extract; the first and only patented red sorghum leaf extract, a phenolic-rich botanical extract marketed for dietary supplement, functional food and beverage, and cosmetic applications.

Products and services

  • ReDaxin™ ReDaxin™ is the first and only patented red sorghum leaf extract — a phenolic-rich botanical extract (>20% polyphenols, including luteolin, quercetin, hydroxycinnamic acids, and rare 3-deoxyanthocyanidins) produced via a proprietary aqueous extraction process. It is supplied as a formulation-ready bioactive raw ingredient for dietary supplement, functional food and beverage, and cosmetic applications, available in formats including capsules/tablets, ready-to-drink beverages, powders/stick packs, gummies/gels, functional foods, and cosmetic applications. Demonstrated functionality includes muscle strength recovery support, reduced muscle soreness, antioxidant activity, anti-inflammatory action, and immune modulation, with a University of Kentucky clinical study supporting the muscle strength recovery claim.

Companies that use RedLeaf Biologics

Customer profile

Ideal customer profiles1 record

RedLeaf Biologics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

RedLeaf Biologics partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

RedLeaf Biologics competitors and assessment

Company assessment

Broad incumbents

  • Kemin Industries: Global ingredient manufacturer supplying natural antioxidants, colorants, and antimicrobials to F&B, supplement, and pet/animal nutrition formulators. Comparable to RedLeaf as a botanical/bioactive ingredient supplier targeting the same B2B customer base, though Kemin operates a vastly larger, multi-ingredient portfolio.
  • ADM (Archer Daniels Midland): Major agribusiness with a large Nutrition and Health Solutions segment supplying plant-based extracts, natural colors, and functional ingredients to F&B and supplement manufacturers. Directly comparable to RedLeaf on supply-side agronomy and ingredient-channel economics, with much greater scale.
  • Givaudan (incl. Naturex): Through its Naturex acquisition, Givaudan is one of the largest suppliers of botanical extracts, natural colors, and fruit/vegetable-derived ingredients to F&B and nutraceutical formulators globally. Closest direct peer in the natural polyphenol/botanical extract category, but at incumbent scale.
  • Chr. Hansen (now Novonesis): Global bioscience company supplying natural colors, antioxidants, and antimicrobial cultures to food and beverage manufacturers. Directly comparable on the natural colorant + antioxidant + antimicrobial function that RedLeaf is targeting, though at incumbent scale.

Direct peers

  • Indena S.p.A. Italian botanical extract specialist supplying high-purity, clinically supported plant-derived active ingredients to dietary supplement, functional food, and cosmetic formulators. Directly comparable to RedLeaf on the botanical-ingredient-for-formulators model and clinical-evidence-led selling motion.
  • Sabinsa: Supplier of patented, clinically-studied branded botanical extracts (e.g., Curcumin C3 Complex, BioPerine) to dietary supplement and functional food manufacturers. Highly comparable go-to-market: patented ingredient + clinical substantiation + B2B sales to formulators.
  • OmniActive Health Technologies: Supplier of proprietary, science-backed botanical extracts (e.g., Lutemax, CurcuWin) to dietary supplement and functional food brands. Comparable branded-ingredient business model with clinical study support and a focus on differentiated polyphenol/carotenoid actives.
  • AIDP Inc. U.S.-based distributor and developer of branded nutraceutical ingredients, including plant extracts, polyphenols, and functional food/beverage actives. Closely comparable in customer base (U.S. supplement and F&B formulators) and ingredient-platform approach.
  • Blue California: Developer of clean-label, plant-based ingredients (e.g., Sondr Sleep, Relissa) sold to CPG and supplement brands. Comparable in positioning around proprietary, branded, natural actives marketed on clinical or mechanistic evidence.
  • FutureCeuticals (by Microbiome Labs): Supplier of proprietary fruit-, vegetable-, and plant-derived ingredient powders and extracts to supplement, beverage, and functional food formulators, with clinical research support. Comparable in the proprietary-ingredient-for-formulators niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

RedLeaf Biologics social profiles

Digital presence

RedLeaf Biologics compliance and trust

Trust signal

Compliance9 records

RedLeaf Biologics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RedLeaf Biologics leadership team

Management profile

Number of profiles

Profiles3 records

RedLeaf Biologics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RedLeaf Biologics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RedLeaf Biologics

What does RedLeaf Biologics do?

RedLeaf Biologics produces and sells ReDaxin™, a patented red sorghum leaf extract — a phenolic-rich (>20% polyphenols, including rare 3-deoxyanthocyanidins) botanical extract manufactured through a proprietary aqueous extraction process. The extract is sold as a formulation-ready bioactive raw ingredient to product manufacturers in the dietary supplement, functional food and beverage, and cosmetics industries, in multiple delivery formats including capsules/tablets, ready-to-drink beverages, powders and stick packs, gummies and gels, and cosmetic applications.

Is RedLeaf Biologics a public or private company?

RedLeaf Biologics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RedLeaf Biologics founded?

RedLeaf Biologics was founded in 2009. It employs 11 to 50 people.

Where is RedLeaf Biologics based?

RedLeaf Biologics is headquartered in Lexington, United States, in the North America region.

How does RedLeaf Biologics make money?

One revenue line is on record: B2B Ingredient Sales to Formulators.

Who are RedLeaf Biologics's main competitors?

Broad incumbents on record are Kemin Industries, ADM (Archer Daniels Midland), Givaudan (incl. Naturex) and Chr. Hansen (now Novonesis). Direct peers are Indena S.p.A., Sabinsa, OmniActive Health Technologies, AIDP Inc., Blue California and FutureCeuticals (by Microbiome Labs).

Does RedLeaf Biologics have an API?

No public API is recorded for RedLeaf Biologics.

What industry is RedLeaf Biologics in?

RedLeaf Biologics's product category is Botanical Extract Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of AFAJAKAI, Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals